Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity of H. Influenzae Type b PRP-OMP Vaccines in American Indian and Alaska Native Children

NCT04978818 is registered in ClinicalTrials.gov with Johns Hopkins Bloomberg School of Public Health as lead sponsor.

NCT NCT04978818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04978818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity of H. Influenzae Type b PRP-OMP Vaccines in American Indian and Alaska Native Children
Lead sponsor
Johns Hopkins Bloomberg School of Public Health
Phase
Phase 4
Overall status
Completed
Start date
January 27, 2022
Completion date
October 26, 2023
Enrollment
333 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

haemophilus influenzae type b infection